Lyxor’s L/S Equity Neutral peer group was down -2.8% year-to-date, hurt by extreme trading conditions and the constituents’ average market beta of 20%. The environment has been challenging for the strategy amid extreme stock volatility and unsettling heavy systematic trading volumes.